nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—AR—duct of salivary gland—head and neck cancer	0.119	0.496	CbGeAlD
Fluoxymesterone—Oligospermia—Hydroxyurea—head and neck cancer	0.043	0.202	CcSEcCtD
Fluoxymesterone—Coma hepatic—Docetaxel—head and neck cancer	0.0373	0.175	CcSEcCtD
Fluoxymesterone—Azoospermia—Hydroxyurea—head and neck cancer	0.0334	0.157	CcSEcCtD
Fluoxymesterone—PRLR—thyroid gland—head and neck cancer	0.0207	0.0866	CbGeAlD
Fluoxymesterone—Amenorrhoea—Hydroxyurea—head and neck cancer	0.0103	0.0481	CcSEcCtD
Fluoxymesterone—SHBG—neck—head and neck cancer	0.00939	0.0393	CbGeAlD
Fluoxymesterone—Menstruation irregular—Docetaxel—head and neck cancer	0.00845	0.0397	CcSEcCtD
Fluoxymesterone—AR—Regulation of Androgen receptor activity—CEBPA—head and neck cancer	0.00841	0.0156	CbGpPWpGaD
Fluoxymesterone—PRLR—ErbB4 signaling events—MAPK1—head and neck cancer	0.00807	0.015	CbGpPWpGaD
Fluoxymesterone—ESR1—Estrogen Receptor Pathway—CYP1A1—head and neck cancer	0.00794	0.0147	CbGpPWpGaD
Fluoxymesterone—NR3C1—FOXA2 and FOXA3 transcription factor networks—CEBPA—head and neck cancer	0.0074	0.0137	CbGpPWpGaD
Fluoxymesterone—SHBG—Nongenotropic Androgen signaling—MAPK3—head and neck cancer	0.00736	0.0137	CbGpPWpGaD
Fluoxymesterone—PRLR—ErbB4 signaling events—PIK3CA—head and neck cancer	0.007	0.013	CbGpPWpGaD
Fluoxymesterone—SHBG—Nongenotropic Androgen signaling—MAPK1—head and neck cancer	0.007	0.013	CbGpPWpGaD
Fluoxymesterone—AR—Nuclear Receptor transcription pathway—RARB—head and neck cancer	0.00674	0.0125	CbGpPWpGaD
Fluoxymesterone—SHBG—connective tissue—head and neck cancer	0.00673	0.0282	CbGeAlD
Fluoxymesterone—ESR1—neck—head and neck cancer	0.00661	0.0277	CbGeAlD
Fluoxymesterone—ESR1—Nuclear Receptors—RARB—head and neck cancer	0.00657	0.0122	CbGpPWpGaD
Fluoxymesterone—NR3C1—Nuclear Receptors—RARB—head and neck cancer	0.00647	0.012	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling events mediated by PTP1B—STAT3—head and neck cancer	0.00647	0.012	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of Androgen receptor activity—CEBPA—head and neck cancer	0.00638	0.0118	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—XRCC1—head and neck cancer	0.00636	0.0118	CbGpPWpGaD
Fluoxymesterone—SHBG—Nongenotropic Androgen signaling—PIK3CA—head and neck cancer	0.00608	0.0113	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling events mediated by PTP1B—EGFR—head and neck cancer	0.00588	0.0109	CbGpPWpGaD
Fluoxymesterone—ESR1—Nuclear signaling by ERBB4—YAP1—head and neck cancer	0.00586	0.0109	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—TGFA—head and neck cancer	0.00564	0.0105	CbGpPWpGaD
Fluoxymesterone—SHBG—Nongenotropic Androgen signaling—HRAS—head and neck cancer	0.00562	0.0104	CbGpPWpGaD
Fluoxymesterone—Amenorrhoea—Docetaxel—head and neck cancer	0.00533	0.025	CcSEcCtD
Fluoxymesterone—ESR1—Nuclear Receptor transcription pathway—RARB—head and neck cancer	0.00519	0.00965	CbGpPWpGaD
Fluoxymesterone—NR3C1—Nuclear Receptor transcription pathway—RARB—head and neck cancer	0.00512	0.0095	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling events mediated by PTP1B—PIK3CA—head and neck cancer	0.0051	0.00947	CbGpPWpGaD
Fluoxymesterone—Haemoglobin—Vinblastine—head and neck cancer	0.00499	0.0234	CcSEcCtD
Fluoxymesterone—SHBG—Nongenotropic Androgen signaling—AKT1—head and neck cancer	0.00496	0.00922	CbGpPWpGaD
Fluoxymesterone—Haemorrhage—Vinblastine—head and neck cancer	0.00496	0.0233	CcSEcCtD
Fluoxymesterone—NR3C1—neck—head and neck cancer	0.00488	0.0204	CbGeAlD
Fluoxymesterone—AR—connective tissue—head and neck cancer	0.00483	0.0202	CbGeAlD
Fluoxymesterone—ESR1—connective tissue—head and neck cancer	0.00474	0.0198	CbGeAlD
Fluoxymesterone—AR—epithelium—head and neck cancer	0.00458	0.0192	CbGeAlD
Fluoxymesterone—Haemoglobin—Hydroxyurea—head and neck cancer	0.00455	0.0213	CcSEcCtD
Fluoxymesterone—Haemorrhage—Hydroxyurea—head and neck cancer	0.00452	0.0212	CcSEcCtD
Fluoxymesterone—ESR1—epithelium—head and neck cancer	0.0045	0.0188	CbGeAlD
Fluoxymesterone—SHBG—thyroid gland—head and neck cancer	0.00447	0.0187	CbGeAlD
Fluoxymesterone—Alopecia—Vinblastine—head and neck cancer	0.00438	0.0206	CcSEcCtD
Fluoxymesterone—PRLR—Signaling events mediated by PTP1B—AKT1—head and neck cancer	0.00417	0.00774	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—XRCC3—head and neck cancer	0.00408	0.00758	CbGpPWpGaD
Fluoxymesterone—Alopecia—Hydroxyurea—head and neck cancer	0.004	0.0188	CcSEcCtD
Fluoxymesterone—NR3C1—parotid gland—head and neck cancer	0.00397	0.0166	CbGeAlD
Fluoxymesterone—NR3C1—saliva-secreting gland—head and neck cancer	0.00381	0.0159	CbGeAlD
Fluoxymesterone—ESR1—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.00368	0.00684	CbGpPWpGaD
Fluoxymesterone—AR—lymphoid tissue—head and neck cancer	0.00353	0.0148	CbGeAlD
Fluoxymesterone—NR3C1—connective tissue—head and neck cancer	0.0035	0.0146	CbGeAlD
Fluoxymesterone—ESR1—lymphoid tissue—head and neck cancer	0.00347	0.0145	CbGeAlD
Fluoxymesterone—NR3C1—epithelium—head and neck cancer	0.00332	0.0139	CbGeAlD
Fluoxymesterone—Haemoglobin—Fluorouracil—head and neck cancer	0.00327	0.0154	CcSEcCtD
Fluoxymesterone—Haemorrhage—Fluorouracil—head and neck cancer	0.00326	0.0153	CcSEcCtD
Fluoxymesterone—AR—thyroid gland—head and neck cancer	0.00321	0.0134	CbGeAlD
Fluoxymesterone—Paraesthesia—Vinblastine—head and neck cancer	0.00316	0.0149	CcSEcCtD
Fluoxymesterone—ESR1—Estrogen signaling pathway—BCL2—head and neck cancer	0.00315	0.00585	CbGpPWpGaD
Fluoxymesterone—ESR1—thyroid gland—head and neck cancer	0.00315	0.0132	CbGeAlD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—XRCC3—head and neck cancer	0.00315	0.00584	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—CEBPA—head and neck cancer	0.00311	0.00578	CbGpPWpGaD
Fluoxymesterone—PRLR—Adipogenesis—STAT3—head and neck cancer	0.00311	0.00577	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—PTEN—head and neck cancer	0.00307	0.00569	CbGpPWpGaD
Fluoxymesterone—AR—Notch-mediated HES/HEY network—NOTCH1—head and neck cancer	0.00295	0.00548	CbGpPWpGaD
Fluoxymesterone—Clobetasol propionate—CYP1A1—head and neck cancer	0.00294	0.303	CrCbGaD
Fluoxymesterone—NR3C1—trachea—head and neck cancer	0.00294	0.0123	CbGeAlD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.00289	0.00536	CbGpPWpGaD
Fluoxymesterone—Alopecia—Fluorouracil—head and neck cancer	0.00288	0.0135	CcSEcCtD
Fluoxymesterone—AR—head—head and neck cancer	0.00284	0.0119	CbGeAlD
Fluoxymesterone—ESR1—head—head and neck cancer	0.00279	0.0117	CbGeAlD
Fluoxymesterone—PRLR—Signaling by ERBB4—MAPK3—head and neck cancer	0.00262	0.00487	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Vinblastine—head and neck cancer	0.0026	0.0122	CcSEcCtD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—RAD51—head and neck cancer	0.00257	0.00478	CbGpPWpGaD
Fluoxymesterone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—head and neck cancer	0.00256	0.00475	CbGpPWpGaD
Fluoxymesterone—NR3C1—lymphoid tissue—head and neck cancer	0.00256	0.0107	CbGeAlD
Fluoxymesterone—PRLR—Signaling by ERBB4—MAPK1—head and neck cancer	0.00249	0.00463	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—EGFR—head and neck cancer	0.00249	0.00463	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—STAT6—head and neck cancer	0.00249	0.00462	CbGpPWpGaD
Fluoxymesterone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—head and neck cancer	0.00243	0.00452	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—STAT6—head and neck cancer	0.00238	0.00442	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00237	0.0111	CcSEcCtD
Fluoxymesterone—Haemoglobin—Docetaxel—head and neck cancer	0.00236	0.0111	CcSEcCtD
Fluoxymesterone—Haemorrhage—Docetaxel—head and neck cancer	0.00235	0.011	CcSEcCtD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.00234	0.00435	CbGpPWpGaD
Fluoxymesterone—NR3C1—thyroid gland—head and neck cancer	0.00232	0.00973	CbGeAlD
Fluoxymesterone—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00231	0.0109	CcSEcCtD
Fluoxymesterone—AR—Nongenotropic Androgen signaling—MAPK3—head and neck cancer	0.00228	0.00423	CbGpPWpGaD
Fluoxymesterone—Headache—Vinblastine—head and neck cancer	0.00221	0.0104	CcSEcCtD
Fluoxymesterone—AR—Coregulation of Androgen receptor activity—CASP8—head and neck cancer	0.00218	0.00405	CbGpPWpGaD
Fluoxymesterone—AR—Nongenotropic Androgen signaling—MAPK1—head and neck cancer	0.00217	0.00403	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—PIK3CA—head and neck cancer	0.00216	0.00402	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—head and neck cancer	0.00214	0.00397	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.00213	0.00396	CbGpPWpGaD
Fluoxymesterone—ESR1—Estrogen signaling pathway—MAPK1—head and neck cancer	0.00212	0.00394	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—BCL2L1—head and neck cancer	0.00211	0.00392	CbGpPWpGaD
Fluoxymesterone—Nausea—Vinblastine—head and neck cancer	0.00209	0.00982	CcSEcCtD
Fluoxymesterone—Paraesthesia—Fluorouracil—head and neck cancer	0.00208	0.00975	CcSEcCtD
Fluoxymesterone—Alopecia—Docetaxel—head and neck cancer	0.00208	0.00975	CcSEcCtD
Fluoxymesterone—NR3C1—head—head and neck cancer	0.00206	0.00863	CbGeAlD
Fluoxymesterone—Headache—Hydroxyurea—head and neck cancer	0.00201	0.00945	CcSEcCtD
Fluoxymesterone—PRLR—Signaling by ERBB4—HRAS—head and neck cancer	0.002	0.00372	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—IL2—head and neck cancer	0.002	0.00371	CbGpPWpGaD
Fluoxymesterone—AR—lymph node—head and neck cancer	0.00199	0.00834	CbGeAlD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—RAD51—head and neck cancer	0.00198	0.00368	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—YAP1—head and neck cancer	0.00197	0.00366	CbGpPWpGaD
Fluoxymesterone—ESR1—lymph node—head and neck cancer	0.00196	0.00819	CbGeAlD
Fluoxymesterone—PRLR—Signaling Pathways—KISS1—head and neck cancer	0.00192	0.00357	CbGpPWpGaD
Fluoxymesterone—Nausea—Hydroxyurea—head and neck cancer	0.00191	0.00896	CcSEcCtD
Fluoxymesterone—AR—Nongenotropic Androgen signaling—PIK3CA—head and neck cancer	0.00188	0.00349	CbGpPWpGaD
Fluoxymesterone—ESR1—Estrogen signaling pathway—PIK3CA—head and neck cancer	0.00184	0.00342	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.00181	0.00335	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—AKT1—head and neck cancer	0.00177	0.00328	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—BCL2L1—head and neck cancer	0.00174	0.00324	CbGpPWpGaD
Fluoxymesterone—AR—Nongenotropic Androgen signaling—HRAS—head and neck cancer	0.00174	0.00323	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—head and neck cancer	0.00174	0.00322	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.00172	0.00319	CbGpPWpGaD
Fluoxymesterone—AR—Notch-mediated HES/HEY network—STAT3—head and neck cancer	0.00171	0.00317	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Fluorouracil—head and neck cancer	0.0017	0.008	CcSEcCtD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—STAT3—head and neck cancer	0.00168	0.00312	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Docetaxel—head and neck cancer	0.00167	0.00784	CcSEcCtD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—CCND1—head and neck cancer	0.00167	0.0031	CbGpPWpGaD
Fluoxymesterone—NR3C1—Endoderm Differentiation—NOTCH1—head and neck cancer	0.00167	0.00309	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.00164	0.00305	CbGpPWpGaD
Fluoxymesterone—AR—Coregulation of Androgen receptor activity—CCND1—head and neck cancer	0.00161	0.00299	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—MAPK3—head and neck cancer	0.00161	0.00298	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—GRP—head and neck cancer	0.00158	0.00294	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—STAT6—head and neck cancer	0.00154	0.00286	CbGpPWpGaD
Fluoxymesterone—AR—Nongenotropic Androgen signaling—AKT1—head and neck cancer	0.00154	0.00285	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—MAPK1—head and neck cancer	0.00153	0.00284	CbGpPWpGaD
Fluoxymesterone—ESR1—Estrogen signaling pathway—AKT1—head and neck cancer	0.0015	0.00279	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Docetaxel—head and neck cancer	0.0015	0.00704	CcSEcCtD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—BCL2—head and neck cancer	0.00148	0.00275	CbGpPWpGaD
Fluoxymesterone—Headache—Fluorouracil—head and neck cancer	0.00145	0.0068	CcSEcCtD
Fluoxymesterone—NR3C1—lymph node—head and neck cancer	0.00144	0.00604	CbGeAlD
Fluoxymesterone—Triamcinolone—PTGS2—head and neck cancer	0.00144	0.149	CrCbGaD
Fluoxymesterone—Nausea—Fluorouracil—head and neck cancer	0.00137	0.00645	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—YAP1—head and neck cancer	0.00136	0.00253	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.00135	0.00251	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—PIK3CA—head and neck cancer	0.00133	0.00246	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—head and neck cancer	0.00129	0.0024	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.00128	0.00238	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—head and neck cancer	0.00127	0.00236	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—CCND1—head and neck cancer	0.00127	0.00236	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Docetaxel—head and neck cancer	0.00123	0.00577	CcSEcCtD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—HRAS—head and neck cancer	0.00123	0.00228	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.00122	0.00226	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.00122	0.00226	CbGpPWpGaD
Fluoxymesterone—Progesterone—CYP1A1—head and neck cancer	0.0012	0.124	CrCbGaD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—head and neck cancer	0.00119	0.00221	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—CCND1—head and neck cancer	0.00119	0.00221	CbGpPWpGaD
Fluoxymesterone—Betamethasone—PTGS2—head and neck cancer	0.00118	0.122	CrCbGaD
Fluoxymesterone—AR—Generic Transcription Pathway—RARB—head and neck cancer	0.00116	0.00216	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—IL2—head and neck cancer	0.00116	0.00216	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—head and neck cancer	0.00116	0.00215	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—PTEN—head and neck cancer	0.00115	0.00213	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—IL2—head and neck cancer	0.00114	0.00211	CbGpPWpGaD
Fluoxymesterone—Testosterone—CYP1A1—head and neck cancer	0.00114	0.117	CrCbGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—CCND1—head and neck cancer	0.00114	0.00211	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—IL2—head and neck cancer	0.00112	0.00208	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—CCND1—head and neck cancer	0.00111	0.00206	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—CYP1A1—head and neck cancer	0.0011	0.113	CrCbGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CCND1—head and neck cancer	0.00109	0.00203	CbGpPWpGaD
Fluoxymesterone—ESR1—LKB1 signaling events—TP53—head and neck cancer	0.00108	0.002	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—HRAS—head and neck cancer	0.00107	0.00199	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—PTEN—head and neck cancer	0.00107	0.00199	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—YAP1—head and neck cancer	0.00106	0.00197	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—BCL2L1—head and neck cancer	0.00106	0.00196	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CASP8—head and neck cancer	0.00106	0.00196	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—PTEN—head and neck cancer	0.00105	0.00196	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—CCND1—head and neck cancer	0.00105	0.00195	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—MAPK3—head and neck cancer	0.00105	0.00195	CbGpPWpGaD
Fluoxymesterone—Headache—Docetaxel—head and neck cancer	0.00105	0.00491	CcSEcCtD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CDH1—head and neck cancer	0.00104	0.00194	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—STAT3—head and neck cancer	0.00103	0.0019	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—MAPK1—head and neck cancer	0.000998	0.00185	CbGpPWpGaD
Fluoxymesterone—Nausea—Docetaxel—head and neck cancer	0.000992	0.00465	CcSEcCtD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—IL2—head and neck cancer	0.000987	0.00183	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000987	0.00183	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	0.000978	0.00182	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—AKT1—head and neck cancer	0.000947	0.00176	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—MAPK3—head and neck cancer	0.000936	0.00174	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—EGFR—head and neck cancer	0.000932	0.00173	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—BCL2—head and neck cancer	0.000907	0.00168	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—STAT3—head and neck cancer	0.000906	0.00168	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—RARB—head and neck cancer	0.000897	0.00167	CbGpPWpGaD
Fluoxymesterone—AR—Coregulation of Androgen receptor activity—AKT1—head and neck cancer	0.000894	0.00166	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—MAPK1—head and neck cancer	0.000891	0.00165	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—EGFR—head and neck cancer	0.000891	0.00165	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—RARB—head and neck cancer	0.000884	0.00164	CbGpPWpGaD
Fluoxymesterone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	0.000881	0.00164	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000876	0.00163	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—MAPK3—head and neck cancer	0.000866	0.00161	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CASP8—head and neck cancer	0.000864	0.0016	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CDH1—head and neck cancer	0.000854	0.00159	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—MAPK1—head and neck cancer	0.000824	0.00153	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—YAP1—head and neck cancer	0.000816	0.00152	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CASP8—head and neck cancer	0.000814	0.00151	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CDH1—head and neck cancer	0.000804	0.00149	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—YAP1—head and neck cancer	0.000804	0.00149	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—head and neck cancer	0.000794	0.00147	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	0.000778	0.00145	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—head and neck cancer	0.000755	0.0014	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000751	0.0014	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	0.000751	0.0014	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—BCL2—head and neck cancer	0.000742	0.00138	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TP53—head and neck cancer	0.000731	0.00136	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TP53—head and neck cancer	0.00072	0.00134	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.000714	0.00133	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	0.000713	0.00132	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—BCL2—head and neck cancer	0.000699	0.0013	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—PTGS2—head and neck cancer	0.000687	0.0709	CrCbGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	0.000679	0.00126	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000675	0.00125	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—HRAS—head and neck cancer	0.000661	0.00123	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000661	0.00123	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—AKT1—head and neck cancer	0.000661	0.00123	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL2—head and neck cancer	0.000653	0.00121	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000645	0.0012	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—TP53—head and neck cancer	0.000634	0.00118	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—AKT1—head and neck cancer	0.000631	0.00117	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000623	0.00116	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PTEN—head and neck cancer	0.000614	0.00114	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NOTCH1—head and neck cancer	0.000613	0.00114	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	0.000611	0.00113	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	0.000611	0.00113	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	0.0006	0.00111	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—AKT1—head and neck cancer	0.000584	0.00108	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000579	0.00108	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	0.000579	0.00107	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PTEN—head and neck cancer	0.000576	0.00107	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—STAT3—head and neck cancer	0.000575	0.00107	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.000562	0.00104	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—RARB—head and neck cancer	0.000561	0.00104	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.00055	0.00102	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—STAT3—head and neck cancer	0.000549	0.00102	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	0.000549	0.00102	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	0.000541	0.001	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—head and neck cancer	0.000535	0.000994	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000532	0.000988	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—MAPK3—head and neck cancer	0.000525	0.000975	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	0.000523	0.000971	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—TP53—head and neck cancer	0.000513	0.000952	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—YAP1—head and neck cancer	0.00051	0.000948	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.000506	0.00094	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.000506	0.00094	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000502	0.000932	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—MAPK1—head and neck cancer	0.000499	0.000927	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—EGFR—head and neck cancer	0.000499	0.000927	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000497	0.000923	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—MAPK3—head and neck cancer	0.000492	0.000914	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.00048	0.000891	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000478	0.000887	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	0.000471	0.000874	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	0.00047	0.000874	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—MAPK1—head and neck cancer	0.000468	0.000869	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—EGFR—head and neck cancer	0.000468	0.000869	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000439	0.000816	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PIK3CA—head and neck cancer	0.000433	0.000805	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.000433	0.000804	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	0.000433	0.000804	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—RARB—head and neck cancer	0.000432	0.000802	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—RARB—head and neck cancer	0.000425	0.00079	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000425	0.000789	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL2—head and neck cancer	0.000422	0.000784	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCND1—head and neck cancer	0.000411	0.000764	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.00041	0.000761	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PIK3CA—head and neck cancer	0.000406	0.000754	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—HRAS—head and neck cancer	0.000401	0.000745	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PTEN—head and neck cancer	0.000397	0.000738	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—TP53—head and neck cancer	0.000395	0.000734	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—YAP1—head and neck cancer	0.000393	0.00073	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.00039	0.000724	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.00039	0.000724	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—YAP1—head and neck cancer	0.000387	0.000719	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—HRAS—head and neck cancer	0.000376	0.000698	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000368	0.000683	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000362	0.000673	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KISS1—head and neck cancer	0.000361	0.000671	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000359	0.000666	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—VEGFA—head and neck cancer	0.000359	0.000666	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—STAT3—head and neck cancer	0.000355	0.00066	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—AKT1—head and neck cancer	0.000354	0.000657	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MAPK3—head and neck cancer	0.000339	0.00063	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000338	0.000628	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	0.000334	0.000619	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—AKT1—head and neck cancer	0.000332	0.000616	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000327	0.000608	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MAPK1—head and neck cancer	0.000323	0.0006	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EGFR—head and neck cancer	0.000323	0.0006	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GRP—head and neck cancer	0.000297	0.000552	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—STAT6—head and neck cancer	0.000289	0.000536	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CA—head and neck cancer	0.00028	0.00052	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000276	0.000513	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TP53—head and neck cancer	0.000271	0.000503	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HRAS—head and neck cancer	0.000259	0.000481	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—YAP1—head and neck cancer	0.000256	0.000475	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NOTCH1—head and neck cancer	0.00023	0.000427	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—AKT1—head and neck cancer	0.000229	0.000425	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NOTCH1—head and neck cancer	0.000177	0.000329	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NOTCH1—head and neck cancer	0.000174	0.000324	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—MAPK3—head and neck cancer	0.000127	0.000236	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NOTCH1—head and neck cancer	0.000115	0.000214	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—MAPK3—head and neck cancer	9.8e-05	0.000182	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—MAPK3—head and neck cancer	9.65e-05	0.000179	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—AKT1—head and neck cancer	8.58e-05	0.000159	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL2—head and neck cancer	7.93e-05	0.000147	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCND1—head and neck cancer	7.73e-05	0.000143	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PTEN—head and neck cancer	7.46e-05	0.000138	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—VEGFA—head and neck cancer	6.74e-05	0.000125	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—STAT3—head and neck cancer	6.67e-05	0.000124	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—AKT1—head and neck cancer	6.61e-05	0.000123	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—AKT1—head and neck cancer	6.51e-05	0.000121	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MAPK3—head and neck cancer	6.37e-05	0.000118	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MAPK1—head and neck cancer	6.06e-05	0.000113	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EGFR—head and neck cancer	6.06e-05	0.000113	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CA—head and neck cancer	5.26e-05	9.77e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TP53—head and neck cancer	5.09e-05	9.45e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HRAS—head and neck cancer	4.87e-05	9.04e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKT1—head and neck cancer	4.3e-05	7.98e-05	CbGpPWpGaD
